Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -11.10%-218.66K | -15.65%-238.42K | 81.16%-4.13K | 65.12%-70.32K | 1,507.98%524.12K | -215.49%-196.81K | -277.50%-206.15K | -179.31%-21.92K | -15.85%-201.58K | -48.77%-37.23K |
| Net income from continuing operations | -18.29%-233.13K | -13.34%-225.45K | -13.84%-220.45K | -31.34%-799.37K | 6.36%-209.72K | -6.38%-197.08K | -55.72%-198.92K | -170.28%-193.66K | -29.22%-608.62K | -107.77%-223.97K |
| Other non cashItems | ---- | ---- | ---- | 54.23%591.31K | ---- | ---- | ---- | ---- | --383.38K | ---- |
| Change In working capital | 5,220.96%14.47K | -79.27%-12.96K | 25.96%216.32K | 482.25%137.75K | 172.48%142.53K | -99.78%272 | -109.89%-7.23K | 72.97%171.74K | -92.03%23.66K | -337.56%-196.64K |
| -Change in receivables | -279.25%-1.05K | -83.98%355 | -198.84%-85 | 415.22%2.84K | -100.09%-41 | 120.65%583 | 170.90%2.22K | 100.21%86 | 118.54%552 | 962.01%43.78K |
| -Change in prepaid assets | --6.76K | --0 | ---7.47K | --0 | --0 | --0 | --0 | --0 | 0.00%2.5K | --0 |
| -Change in payables and accrued expense | 2,916.08%8.76K | -40.98%-13.32K | 30.43%223.88K | 554.69%134.91K | 159.30%142.58K | -100.25%-311 | -113.53%-9.45K | 22.17%171.65K | -93.07%20.61K | -415.70%-240.42K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -11.10%-218.66K | -15.65%-238.42K | 81.16%-4.13K | 65.12%-70.32K | 1,507.98%524.12K | -215.49%-196.81K | -277.50%-206.15K | -179.31%-21.92K | -15.85%-201.58K | -48.77%-37.23K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 6.97K | 0 | 0 | 0 | 0 | 0 | 111.07%12.85K | 308.62%37.94K |
| Net PPE purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other investing changes | ---- | ---- | --6.97K | ---- | ---- | ---- | ---- | ---- | 111.07%12.85K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --6.97K | --0 | --0 | --0 | --0 | --0 | 111.07%12.85K | 308.62%37.94K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 9.66%212.52K | 14.92%241.61K | -74.56%52.79K | -4,106.32%-520.82K | 174.89%193.8K | 329.08%210.25K | 23.88%207.5K | -72.04%13K | ||
| Net issuance payments of debt | 9.66%212.52K | 14.92%241.61K | ---- | -74.56%52.79K | -4,106.32%-520.82K | 174.89%193.8K | 329.08%210.25K | ---- | 50.91%207.5K | -72.04%13K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 9.66%212.52K | 14.92%241.61K | ---- | -74.56%52.79K | -4,106.32%-520.82K | 174.89%193.8K | 329.08%210.25K | ---- | 23.88%207.5K | -72.04%13K |
| Net cash flow | ||||||||||
| Beginning cash position | 133.11%11.08K | 1,112.15%7.88K | -77.66%5.04K | 494.21%22.57K | -80.33%1.74K | 547.28%4.75K | -89.75%650 | 494.21%22.57K | -96.99%3.8K | 1,645.76%8.85K |
| Current changes in cash | -103.92%-6.14K | -22.07%3.2K | 112.95%2.84K | -193.38%-17.53K | -75.94%3.3K | -137.08%-3.01K | 173.11%4.1K | -961.22%-21.92K | 115.32%18.77K | 316.80%13.72K |
| End cash Position | 183.57%4.94K | 133.11%11.08K | 1,112.15%7.88K | -77.66%5.04K | -77.66%5.04K | -80.33%1.74K | 547.28%4.75K | -89.75%650 | 494.21%22.57K | 494.21%22.57K |
| Free cash from | -11.10%-218.66K | -15.65%-238.42K | 81.16%-4.13K | 65.12%-70.32K | 4,419.45%524.12K | -215.49%-196.81K | -277.50%-206.15K | -179.31%-21.92K | -15.85%-201.58K | -116.66%-12.13K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.